Search

everythinglearnresearchcommunity

for

Search:↓

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Kimchi probiotics slightly improved hair density, but more research needed.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Certain gene variations might be linked to severe acne in women but not in men.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

People with polycystic ovary syndrome are more likely to have poor sleep, restless legs syndrome, anxiety, and depression.

Clascoterone is safe for the heart, even at high doses.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

PCOS is common among young Saudi medical students, with symptoms like hair loss, acne, and weight gain.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

VDR gene variations may affect carbohydrate metabolism in young women with hyperandrogenism.